Leaflet VIMAPRIL H 10mg / 25mg tablets


Indicated for: hypertension

Substance: enalapril + hydrochlorothiazide (ACE inhibitor + diuretic)

ATC: C09BA02 (Cardiovascular system | Ace inhibitors, combinations | Ace inhibitors and diuretics)

The combination of Enalaprilum + Hydrochlorothiazidum is used for the treatment of essential hypertension in patients who do not respond adequately to monotherapy. It combines an angiotensin-converting enzyme (ACE) inhibitor (enalaprilum) with a thiazide diuretic (hydrochlorothiazidum) to lower blood pressure.

The medication is taken orally, usually once daily, and is effective in reducing the risk of cardiovascular complications such as stroke or heart failure.

Side effects may include dizziness, dry cough, nausea, hypokalemia, or increased uric acid levels. It is important to monitor blood pressure and kidney function during treatment.

Consult your doctor to discuss the benefits and risks of treatment with this combination. Follow the prescribed dosage and adhere to all medical recommendations.

General data about VIMAPRIL H 10mg / 25mg

  • Substance: enalapril + hydrochlorothiazide
  • Date of last drug list: 01-06-2016
  • Commercial code: W13185003
  • Concentration: 10mg / 25mg
  • Pharmaceutical form: tablets
  • Quantity: 30
  • Product type: generic
  • Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Concentrations available for enalapril + hydrochlorothiazide

  • 10mg/12.5mg
  • 10mg/25mg
  • 20mg/12.5mg